Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment.
| ChEMBL ID | Target Similarity | Compound Similarity | Reference | Title | PubMed ID | DOI |
|---|---|---|---|---|---|---|
| Loading items... | ||||||
ChEMBL is part of the ELIXIR infrastructure
ChEMBL is and Elixir Core Data Resource
Learn More
ChEMBL is a Global Core Biodata Resource